Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
22
SHWZ Quote, Financials, Valuation and Earnings
Last price:
$0.0000
Seasonality move
:
3.37%
Day range:
$0.0001 - $0.0001
52-week range:
$0.0000 - $0.1300
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.00x
P/B ratio:
0.00x
Volume:
--
Avg. volume:
25.7K
1-year change:
-100%
Market cap:
$100
Revenue:
$172.4M
EPS (TTM):
-$0.81
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SHWZ
Medicine Man Technologies, Inc.
|
$44.3M | -$0.19 | 2.71% | -566.67% | $1.4350 |
|
ALST
AllStar Health Brands, Inc.
|
-- | -- | -- | -- | -- |
|
DECN
Decision Diagnostics Corp.
|
-- | -- | -- | -- | -- |
|
MDVLQ
MedAvail Holdings, Inc.
|
-- | -- | -- | -- | -- |
|
RNBI
Rainbow International Corp.
|
-- | -- | -- | -- | -- |
|
SCRCQ
ScripsAmerica, Inc.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SHWZ
Medicine Man Technologies, Inc.
|
$0.0000 | $1.4350 | $100 | -- | $0.00 | 0% | 0.00x |
|
ALST
AllStar Health Brands, Inc.
|
$0.0005 | -- | -- | -- | $0.00 | 0% | -- |
|
DECN
Decision Diagnostics Corp.
|
$0.0000 | -- | $400 | -- | $0.00 | 0% | 0.00x |
|
MDVLQ
MedAvail Holdings, Inc.
|
$0.0000 | -- | -- | -- | $0.00 | 0% | 0.00x |
|
RNBI
Rainbow International Corp.
|
$0.0000 | -- | $300 | -- | $0.00 | 0% | -- |
|
SCRCQ
ScripsAmerica, Inc.
|
$0.0000 | -- | $100 | -- | $0.00 | 0% | 0.00x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SHWZ
Medicine Man Technologies, Inc.
|
64.28% | 1.078 | 515.55% | 0.19x |
|
ALST
AllStar Health Brands, Inc.
|
-32.54% | -1.287 | 138765.31% | 0.00x |
|
DECN
Decision Diagnostics Corp.
|
-- | 0.000 | -- | -- |
|
MDVLQ
MedAvail Holdings, Inc.
|
-- | -396.885 | -- | -- |
|
RNBI
Rainbow International Corp.
|
-- | 311.936 | -- | -- |
|
SCRCQ
ScripsAmerica, Inc.
|
-- | 0.000 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SHWZ
Medicine Man Technologies, Inc.
|
$19M | -$2.7M | -17.94% | -39.36% | -3.42% | -- |
|
ALST
AllStar Health Brands, Inc.
|
-- | -$61.3K | -- | -- | -- | -- |
|
DECN
Decision Diagnostics Corp.
|
-- | -- | -- | -- | -- | -- |
|
MDVLQ
MedAvail Holdings, Inc.
|
-- | -- | -- | -- | -- | -- |
|
RNBI
Rainbow International Corp.
|
-- | -- | -- | -- | -- | -- |
|
SCRCQ
ScripsAmerica, Inc.
|
-- | -- | -- | -- | -- | -- |
Medicine Man Technologies, Inc. vs. Competitors
-
Which has Higher Returns SHWZ or ALST?
AllStar Health Brands, Inc. has a net margin of -32.23% compared to Medicine Man Technologies, Inc.'s net margin of --. Medicine Man Technologies, Inc.'s return on equity of -39.36% beat AllStar Health Brands, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SHWZMedicine Man Technologies, Inc.44.05% -$0.20 $254.2M ALSTAllStar Health Brands, Inc.-- -$0.00 -$8.5M -
What do Analysts Say About SHWZ or ALST?
Medicine Man Technologies, Inc. has a consensus price target of $1.4350, signalling upside risk potential of 143499900%. On the other hand AllStar Health Brands, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Medicine Man Technologies, Inc. has higher upside potential than AllStar Health Brands, Inc., analysts believe Medicine Man Technologies, Inc. is more attractive than AllStar Health Brands, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SHWZMedicine Man Technologies, Inc.1 0 0 ALSTAllStar Health Brands, Inc.0 0 0 -
Is SHWZ or ALST More Risky?
Medicine Man Technologies, Inc. has a beta of 1.105, which suggesting that the stock is 10.518% more volatile than S&P 500. In comparison AllStar Health Brands, Inc. has a beta of -0.691, suggesting its less volatile than the S&P 500 by 169.092%.
-
Which is a Better Dividend Stock SHWZ or ALST?
Medicine Man Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AllStar Health Brands, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medicine Man Technologies, Inc. pays -- of its earnings as a dividend. AllStar Health Brands, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SHWZ or ALST?
Medicine Man Technologies, Inc. quarterly revenues are $43.2M, which are larger than AllStar Health Brands, Inc. quarterly revenues of --. Medicine Man Technologies, Inc.'s net income of -$13.9M is lower than AllStar Health Brands, Inc.'s net income of -$198.8K. Notably, Medicine Man Technologies, Inc.'s price-to-earnings ratio is -- while AllStar Health Brands, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medicine Man Technologies, Inc. is 0.00x versus -- for AllStar Health Brands, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SHWZMedicine Man Technologies, Inc.0.00x -- $43.2M -$13.9M ALSTAllStar Health Brands, Inc.-- -- -- -$198.8K
-
Which has Higher Returns SHWZ or DECN?
Decision Diagnostics Corp. has a net margin of -32.23% compared to Medicine Man Technologies, Inc.'s net margin of --. Medicine Man Technologies, Inc.'s return on equity of -39.36% beat Decision Diagnostics Corp.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SHWZMedicine Man Technologies, Inc.44.05% -$0.20 $254.2M DECNDecision Diagnostics Corp.-- -- -- -
What do Analysts Say About SHWZ or DECN?
Medicine Man Technologies, Inc. has a consensus price target of $1.4350, signalling upside risk potential of 143499900%. On the other hand Decision Diagnostics Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Medicine Man Technologies, Inc. has higher upside potential than Decision Diagnostics Corp., analysts believe Medicine Man Technologies, Inc. is more attractive than Decision Diagnostics Corp..
Company Buy Ratings Hold Ratings Sell Ratings SHWZMedicine Man Technologies, Inc.1 0 0 DECNDecision Diagnostics Corp.0 0 0 -
Is SHWZ or DECN More Risky?
Medicine Man Technologies, Inc. has a beta of 1.105, which suggesting that the stock is 10.518% more volatile than S&P 500. In comparison Decision Diagnostics Corp. has a beta of -0.405, suggesting its less volatile than the S&P 500 by 140.514%.
-
Which is a Better Dividend Stock SHWZ or DECN?
Medicine Man Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Decision Diagnostics Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medicine Man Technologies, Inc. pays -- of its earnings as a dividend. Decision Diagnostics Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SHWZ or DECN?
Medicine Man Technologies, Inc. quarterly revenues are $43.2M, which are larger than Decision Diagnostics Corp. quarterly revenues of --. Medicine Man Technologies, Inc.'s net income of -$13.9M is higher than Decision Diagnostics Corp.'s net income of --. Notably, Medicine Man Technologies, Inc.'s price-to-earnings ratio is -- while Decision Diagnostics Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medicine Man Technologies, Inc. is 0.00x versus 0.00x for Decision Diagnostics Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SHWZMedicine Man Technologies, Inc.0.00x -- $43.2M -$13.9M DECNDecision Diagnostics Corp.0.00x -- -- --
-
Which has Higher Returns SHWZ or MDVLQ?
MedAvail Holdings, Inc. has a net margin of -32.23% compared to Medicine Man Technologies, Inc.'s net margin of --. Medicine Man Technologies, Inc.'s return on equity of -39.36% beat MedAvail Holdings, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SHWZMedicine Man Technologies, Inc.44.05% -$0.20 $254.2M MDVLQMedAvail Holdings, Inc.-- -- -- -
What do Analysts Say About SHWZ or MDVLQ?
Medicine Man Technologies, Inc. has a consensus price target of $1.4350, signalling upside risk potential of 143499900%. On the other hand MedAvail Holdings, Inc. has an analysts' consensus of -- which suggests that it could grow by 399900%. Given that Medicine Man Technologies, Inc. has higher upside potential than MedAvail Holdings, Inc., analysts believe Medicine Man Technologies, Inc. is more attractive than MedAvail Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SHWZMedicine Man Technologies, Inc.1 0 0 MDVLQMedAvail Holdings, Inc.0 0 0 -
Is SHWZ or MDVLQ More Risky?
Medicine Man Technologies, Inc. has a beta of 1.105, which suggesting that the stock is 10.518% more volatile than S&P 500. In comparison MedAvail Holdings, Inc. has a beta of -141.282, suggesting its less volatile than the S&P 500 by 14228.248%.
-
Which is a Better Dividend Stock SHWZ or MDVLQ?
Medicine Man Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. MedAvail Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medicine Man Technologies, Inc. pays -- of its earnings as a dividend. MedAvail Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SHWZ or MDVLQ?
Medicine Man Technologies, Inc. quarterly revenues are $43.2M, which are larger than MedAvail Holdings, Inc. quarterly revenues of --. Medicine Man Technologies, Inc.'s net income of -$13.9M is higher than MedAvail Holdings, Inc.'s net income of --. Notably, Medicine Man Technologies, Inc.'s price-to-earnings ratio is -- while MedAvail Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medicine Man Technologies, Inc. is 0.00x versus 0.00x for MedAvail Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SHWZMedicine Man Technologies, Inc.0.00x -- $43.2M -$13.9M MDVLQMedAvail Holdings, Inc.0.00x -- -- --
-
Which has Higher Returns SHWZ or RNBI?
Rainbow International Corp. has a net margin of -32.23% compared to Medicine Man Technologies, Inc.'s net margin of --. Medicine Man Technologies, Inc.'s return on equity of -39.36% beat Rainbow International Corp.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SHWZMedicine Man Technologies, Inc.44.05% -$0.20 $254.2M RNBIRainbow International Corp.-- -- -- -
What do Analysts Say About SHWZ or RNBI?
Medicine Man Technologies, Inc. has a consensus price target of $1.4350, signalling upside risk potential of 143499900%. On the other hand Rainbow International Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Medicine Man Technologies, Inc. has higher upside potential than Rainbow International Corp., analysts believe Medicine Man Technologies, Inc. is more attractive than Rainbow International Corp..
Company Buy Ratings Hold Ratings Sell Ratings SHWZMedicine Man Technologies, Inc.1 0 0 RNBIRainbow International Corp.0 0 0 -
Is SHWZ or RNBI More Risky?
Medicine Man Technologies, Inc. has a beta of 1.105, which suggesting that the stock is 10.518% more volatile than S&P 500. In comparison Rainbow International Corp. has a beta of -63.421, suggesting its less volatile than the S&P 500 by 6442.142%.
-
Which is a Better Dividend Stock SHWZ or RNBI?
Medicine Man Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Rainbow International Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medicine Man Technologies, Inc. pays -- of its earnings as a dividend. Rainbow International Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SHWZ or RNBI?
Medicine Man Technologies, Inc. quarterly revenues are $43.2M, which are larger than Rainbow International Corp. quarterly revenues of --. Medicine Man Technologies, Inc.'s net income of -$13.9M is higher than Rainbow International Corp.'s net income of --. Notably, Medicine Man Technologies, Inc.'s price-to-earnings ratio is -- while Rainbow International Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medicine Man Technologies, Inc. is 0.00x versus -- for Rainbow International Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SHWZMedicine Man Technologies, Inc.0.00x -- $43.2M -$13.9M RNBIRainbow International Corp.-- -- -- --
-
Which has Higher Returns SHWZ or SCRCQ?
ScripsAmerica, Inc. has a net margin of -32.23% compared to Medicine Man Technologies, Inc.'s net margin of --. Medicine Man Technologies, Inc.'s return on equity of -39.36% beat ScripsAmerica, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SHWZMedicine Man Technologies, Inc.44.05% -$0.20 $254.2M SCRCQScripsAmerica, Inc.-- -- -- -
What do Analysts Say About SHWZ or SCRCQ?
Medicine Man Technologies, Inc. has a consensus price target of $1.4350, signalling upside risk potential of 143499900%. On the other hand ScripsAmerica, Inc. has an analysts' consensus of -- which suggests that it could grow by 119999900%. Given that Medicine Man Technologies, Inc. has higher upside potential than ScripsAmerica, Inc., analysts believe Medicine Man Technologies, Inc. is more attractive than ScripsAmerica, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SHWZMedicine Man Technologies, Inc.1 0 0 SCRCQScripsAmerica, Inc.0 0 0 -
Is SHWZ or SCRCQ More Risky?
Medicine Man Technologies, Inc. has a beta of 1.105, which suggesting that the stock is 10.518% more volatile than S&P 500. In comparison ScripsAmerica, Inc. has a beta of -73.458, suggesting its less volatile than the S&P 500 by 7445.781%.
-
Which is a Better Dividend Stock SHWZ or SCRCQ?
Medicine Man Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ScripsAmerica, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medicine Man Technologies, Inc. pays -- of its earnings as a dividend. ScripsAmerica, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SHWZ or SCRCQ?
Medicine Man Technologies, Inc. quarterly revenues are $43.2M, which are larger than ScripsAmerica, Inc. quarterly revenues of --. Medicine Man Technologies, Inc.'s net income of -$13.9M is higher than ScripsAmerica, Inc.'s net income of --. Notably, Medicine Man Technologies, Inc.'s price-to-earnings ratio is -- while ScripsAmerica, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medicine Man Technologies, Inc. is 0.00x versus 0.00x for ScripsAmerica, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SHWZMedicine Man Technologies, Inc.0.00x -- $43.2M -$13.9M SCRCQScripsAmerica, Inc.0.00x -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
